SOLACI Research | Invitation to Participate in the Latin American SOLACI Peripheral Registry

After much effort, SOLACI Research is pleased to formally invite the entire community to participate in the Latin American SOLACI Peripheral Registry, our second research initiative. 

SOLACI Research Registro Peripheral

The SOLACI Peripheral Registry is a multicenter, prospective registry that aims to collect data on the reality of lower limb angioplasty in Latin America, in order to unify criteria, draw conclusions, and develop strategies to improve daily practice in this type of procedure.

It should be noted that SOLACI Peripheral is a research program open to all centers in Latin America that may be willing to actively participate; in this sense, each participant center will have access to registry data in real time. Furthermore, participants will have authorship rights in all Registry publications and will secure the possibility of using Registry data for their own research projects. 

The benefits of participating

  1. Access our own database dedicated to lower limb angioplasty, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present SOLACI Peripheral outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

Your participation is really important to SOLACI and to the entire SOLACI Peripheral Committee. We would be pleased and honored to have you join us in this important initiative.

To take part of SOLACI Peripheral Registry, please email us to: research@solaci.org

Sincerely,


Relive the SOLACI Peripheral Registry Launch!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...